- Home
- PWM vs SLGL Comparison
PWM vs SLGL Comparison
Compare PWM & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWM
- SLGL
- Stock Information
- Founded
- PWM 2018
- SLGL 1997
- Country
- PWM Hong Kong
- SLGL Israel
- Employees
- PWM N/A
- SLGL N/A
- Industry
- PWM
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- PWM
- SLGL Health Care
- Exchange
- PWM Nasdaq
- SLGL Nasdaq
- Market Cap
- PWM 17.6M
- SLGL 18.3M
- IPO Year
- PWM 2023
- SLGL 2018
- Fundamental
- Price
- PWM $1.38
- SLGL $0.48
- Analyst Decision
- PWM
- SLGL Strong Buy
- Analyst Count
- PWM 0
- SLGL 2
- Target Price
- PWM N/A
- SLGL $5.00
- AVG Volume (30 Days)
- PWM 305.7K
- SLGL 54.9K
- Earning Date
- PWM 12-24-2024
- SLGL 11-15-2024
- Dividend Yield
- PWM N/A
- SLGL N/A
- EPS Growth
- PWM N/A
- SLGL N/A
- EPS
- PWM N/A
- SLGL N/A
- Revenue
- PWM $348,528.00
- SLGL $11,707,000.00
- Revenue This Year
- PWM N/A
- SLGL $500.51
- Revenue Next Year
- PWM N/A
- SLGL N/A
- P/E Ratio
- PWM N/A
- SLGL N/A
- Revenue Growth
- PWM N/A
- SLGL 869.93
- 52 Week Low
- PWM $0.67
- SLGL $0.33
- 52 Week High
- PWM $2.64
- SLGL $1.58
- Technical
- Relative Strength Index (RSI)
- PWM 53.71
- SLGL 42.37
- Support Level
- PWM $1.27
- SLGL $0.44
- Resistance Level
- PWM $2.25
- SLGL $0.51
- Average True Range (ATR)
- PWM 0.30
- SLGL 0.04
- MACD
- PWM -0.00
- SLGL -0.00
- Stochastic Oscillator
- PWM 33.08
- SLGL 36.57
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.